Alongside Bpifrance, MACSF and the management team, UI Investissement and GENEO Capital Entrepreneur aim to strengthen Didactic's leading position in the infectious risk prevention and infusion markets, particularly internationally, as part of a project combining sovereignty and re-industrialisation. They are taking over from FCDE, which has been a shareholder for three years.

Founded in 1967 and headed by Frédéric Viguié since 2007, Didactic puts the prevention of iinfectious risks at the heart of healthcare. With the Polysem Medical, Dr Helewa, Hygie and Inter.med brands for infectious risk management and Infineed for infusions, Didactic is helping to limit the spread of hospital-acquired infections while simplifying and protecting the lives of carers for the well-being of patients. With 850 product references, the Group supplies nearly 4,000 customers, mainly public hospitals, as well as private healthcare institutions and vendors. Didactic is the market leader in examination gloves and second in medical hygiene. Thanks to its leading position in France across several product ranges and its commitment to preventing infectious risks, the Group is strategically positioned in fast-growing markets, particularly since the Covid crisis.

Cambon Partners advised Didactic on this LBO and on the financing aspects. Didactic fully incorporates sustainable development in its strategy and has a well-structured CSR policy. Among its concrete initiatives, the "Made in France" infusion project promotes reshoring and reduces the environmental footprint of its products. The Group is also Ecovadis Silver certified, and is committed to limiting its environmental impact while strengthening the sustainability of its supply chains.